The supply of Covid-19 vaccines in the U.S. is increasing and the pace of vaccinations is picking up, and yet the number of new cases is on the rise. Health officials cite vaccine demographics, expanded reopenings, pandemic fatigue and variants as reasons. on.wsj.com
@theconversation.com5 years ago
As U.S. buys up remdesivir, ‘vaccine nationalism’ threatens access to COVID-19 treatments
@politico.com4 years ago
FDA authorizes Johnson & Johnson coronavirus vaccine
@abcnews.go.com4 years ago
Drug execs face Capitol Hill questions on vaccine supply
@abcnews.go.com4 years ago
Drug execs face Capitol Hill questions on vaccine supply
